Interestingly, MRS investigations have also identified lactate resonances in both IDH1 and IDH2 brain malignancies [33], and described IDH2 gliomas as more glycolytic than those harboring the IDH1 mutation [34]. This evidence concerns the gene IDH1 and glioma.